Antipsychotic News and Research

RSS

Antipsychotics are medicines used to treat the symptoms of mental disorders such as schizophrenia, depression, bipolar disorder (sometimes called manic-depressive illness), anxiety disorders, and attention deficit-hyperactivity disorder (ADHD). Sometimes medications are used with other treatments such as psychotherapy.

Researchers identify decreased brain pH levels in mouse models of mental disorders

Your body's acid/alkaline homeostasis, or maintenance of an adequate pH balance in tissues and organs, is important for good health.

7 Aug 2017

New report highlights beneficial effects of nonmedical interventions for people with dementia

Managing lifestyle factors such as hearing loss, smoking, hypertension and depression could prevent one-third of the world's dementia cases, according to a report by the first Lancet Commission on Dementia Prevention and Care.

20 Jul 2017

Screening individuals at-risk for psychosis may help predict future violent behavior

A new study of young persons at clinical high-risk of developing psychosis has identified measures of violence potential that may be useful in predicting both the increased risk of future violent behavior and the actual development of psychosis.

17 Jul 2017

In Texas, people with mental illness find work helping peers

Recovery coaches and peer mentors — known in Alcoholics Anonymous as “sponsors” — have for decades helped those addicted to alcohol or drugs.

13 Jul 2017

Study reveals high use of medications for mental illness in Norwegian nursing homes

For the first time ever, researchers have looked at the long-term use of psychiatric medication in Norwegian nursing homes.

7 Jul 2017

Community-dwelling adults with dementia at risk of potentially fatal antipsychotic usage

Off-label use of antipsychotic medications to treat patients with dementia has reduced dramatically in recent years due to education programs warning of increased risk of death.

27 Jun 2017

Former pharma reps’ new mission: To school docs on high drug costs

As a drug salesman, Mike Courtney worked hard to make health care expensive. He wined and dined doctors, golfed with them and bought lunch for their entire staffs — all to promote pills often costing thousands of dollars a year.

8 Jun 2017

People with severe mental illness have higher risk for cardiovascular disease, study reveals

An international study of more than 3.2 million people with severe mental illness reveals a substantially increased risk for developing cardiovascular disease compared to the general population.

12 May 2017

Personalized music may benefit seniors with dementia living in nursing homes

Across the country, nursing home employees and families are trying personalized music playlists to help seniors cope with the disorienting, anxious experience of living with Alzheimer's disease and related dementias.

10 May 2017

PTSD and psychoactive drugs linked to increased risk for dementia

Researchers are discovering that post-traumatic stress disorder (PTSD) is a significant risk factor in developing dementia.

9 May 2017

Experts find benefits of antipsychotic medications to be much greater than side effects

An international group of experts has concluded that, for patients with schizophrenia and related psychotic disorders, antipsychotic medications do not have negative long-term effects on patients' outcomes or the brain.

5 May 2017

Powerful pain medicine may help reduce vision damage of glaucoma

The tip of our optic nerve is typically the first place injured by glaucoma. Now researchers want to know if the powerful pain medicine (+)-pentazocine can help avoid the damage.

2 May 2017

Study shows possibility to reduce antipsychotic use among nursing home residents with dementia

The use of antipsychotic medication in nearly 100 Massachusetts nursing homes was significantly reduced when staff was trained to recognize challenging behaviors of cognitively impaired residents as communication of their unmet needs, according to a new study led by Jennifer Tjia, MD, MSCE, associate professor of quantitative health sciences.

17 Apr 2017

FDA grants approval for first drug to treat adults with tardive dyskinesia

The U.S. Food and Drug Administration today approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. This is the first drug approved by the FDA for this condition.

11 Apr 2017

New drug can reduce tardive dyskinesia in patients with schizophrenia, mood disorder

Antipsychotic treatment can cause involuntary movements such as lip smacking, tongue protrusions and excessive eye blinking. These movements typically occur after more than 3 months of treatment and are called tardive dyskinesia.

7 Apr 2017

Study provides new insights into side effects of antipsychotics

After much deliberation and anxiety, the family finally sought psychiatric help for their son. And the results were in a way, a relief.

28 Feb 2017

High-dose B vitamins can effectively reduce schizophrenia symptoms, research finds

A review of worldwide studies has found that add-on treatment with high-dose b-vitamins - including B6, B8 and B12 - can significantly reduce symptoms of schizophrenia more than standard treatments alone.

From The University of Manchester 16 Feb 2017

People with schizophrenia more likely to have diabetes than general population

People with early schizophrenia are at an increased risk of developing diabetes, even when the effects of antipsychotic drugs, diet and exercise are taken out of the equation, according to an analysis by researchers from King's College London.

12 Jan 2017

Delirium can be deadly threat to long-term care residents, review finds

A comprehensive review of research published today in The Journal of the American Osteopathic Association finds delirium to be an often-undiagnosed syndrome, affecting nearly 18 percent of long-term care residents, with a staggering 40 percent one-year mortality rate.

9 Jan 2017

Biological Psychiatry special issue highlights role of dopamine signaling in schizophrenia

Biological Psychiatry presents a special issue, "The Dopamine Hypothesis of Schizophrenia", dedicated to recent advances in understanding the role of dopamine signaling in schizophrenia.

2 Jan 2017